By Professor Sallie Pearson

Preprints

Bruno C; Cesta CE; Hjellvik V; Ulrichsen SP; Bjørk M-H; Esen BÖ; Gillies MB; Gissler M; Havard A; Karlstad Ø; Leinonen MK; Nørgaard M; Pearson S-A; Reutfors J; Furu K; Cohen JM; Zoega H, 2023, Antipsychotic Use During Pregnancy and Risk of Specific Neurodevelopmental Disorders and Learning Difficulties in Children: A Multinational Cohort Study, http://dx.doi.org/10.2139/ssrn.4652505

Tuesley KM; Spilsbury K; Webb PM; Protani MM; Dixon-Suen S; Pearson S-A; Donovan P; Coory M; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, Association between Antihypertensive Medicine Use and Risk of Ovarian Cancer in Women Aged 50 Years and Older, http://dx.doi.org/10.2139/ssrn.4414764

Liu B; Stepien S; Dobbins T; Gidding H; Henry D; Korda R; Mills L; Pearson S-A; Pratt N; Vajdic C; Welsh J; Macartney K, 2023, Effectiveness of COVID-19 Vaccination Against Covid-19 Specific and All-Cause Mortality in Older Australians, http://dx.doi.org/10.2139/ssrn.4445191

Costa JDO; Bruno C; Baranwal N; Gisev N; Dobbins T; Degenhardt L; Pearson S-A, 2020, Variations in Long-Term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000–2019), http://dx.doi.org/10.22541/au.160192979.95446629/v1

Daniels B; Girosi F; Tervonen H; Kiely BE; Lord SJ; Houssami N; Pearson S-A, Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: a national population-based observational study (2001-2016), http://dx.doi.org/10.1101/324343

Yin X; Liu H; Webster J; Trieu K; Huffman MD; Miranda JJ; Marklund M; Wu JHY; Cobb LK; Li KC; Pearson S-A; Neal B; Tian M, Availability, Formulation, Labeling, and Price of Low-sodium Salt Worldwide: Environmental Scan (Preprint), http://dx.doi.org/10.2196/preprints.27423

de Oliveira Costa J; Gillies MB; Schaffer AL; Peiris D; Zoega H; Pearson S-A, Changes in antidepressant use in Australia: A nationwide analysis prior to and during the COVID-19 pandemic (2015-2021), http://dx.doi.org/10.1101/2021.11.24.21266837

Schaffer AL; Henry D; Zoega H; Elliott JH; Pearson S-A, Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia, http://dx.doi.org/10.1101/2021.09.26.21264150

Janetzki J; Pratt N; Dalli L; Cataldo-Miranda P; Pearson S-A; Talic S; Kalisch Ellett L, Impact of Australia’s 60-Day Dispensing Policy on Medicine Use: An Interrupted Time Series of the Stage 1 Roll-out, http://dx.doi.org/10.64898/2026.09.09.26362679

Hong S; Daniels B; Leeuwen MT; Pearson S-A; Vajdic CM, Incidence And Risk Factors of Hypertension Therapy In Australian Cancer Patients Treated With Vascular Signalling Pathway Inhibitors, http://dx.doi.org/10.21203/rs.3.rs-1006781/v1

Camacho X; Schaffer AL; Brett J; Hopkins R; Gisev N; Marsh S; Filion KB; Pratt N; Henry D; Pearson S-A, Short-term risk of falls among initiators of controlled-release tapentadol versus oxycodone: A population-based cohort study, http://dx.doi.org/10.64898/2026.01.14.26344133

Falster MO; de Oliveira Costa J; Milder T; Carson J; Shadbolt C; Neuen BL; Arnott C; Wilson A; Jun M; Pratt N; Pearson S-A, The GLP-1 RA boom: Trends in publicly subsidised and private access in Australia, 2020-2025, http://dx.doi.org/10.1101/2025.10.30.25339120

Zoega H; Falster MO; Gillies MB; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer AL; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic CM; Pearson S-A, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520

Back to profile page